Singapore Paincare Holdings is expecting to report a net loss for its upcoming results for the 1HFY2026 ended Dec 31, 2025, reversing from a net profit the year before.
The net loss is attributed to lower revenue and other income and made worse by higher expenses incurred during the six months.
On Feb 3, the company announced that its 51%-owned subsidiary, Dermatology & Laser Specialist Clinic Pte. Ltd., had applied to be wound up pursuant to Section 161(1)(b) of the Insolvency, Restructuring and Dissolution Act 2018.
Tan Wei Cheong and Lim Loo Khoon of Deloitte Singapore SR&T Restructuring Services Pte Ltd, were appointed as the subsidiary’s joint and several provisional liquidators on Feb 2, after the filing of the statutory declaration and the directors’ declaration that Dermatology & Laser Specialist Clinic was unable to continue its business.
An extraordinary general meeting (EGM) of Dermatology & Laser Specialist Clinic’s members and a meeting with its creditors will be convened in due course.
The liquidation is not expected to have a material impact on Singapore Paincare Holdings’ net tangible assets (NTA) or earnings per share (EPS) for the current financial year.
See also: Taka Jewellery guides for ‘significant improvement’ in revenue and net profit for 1HFY2026
On Feb 2, Singapore Paincare Holdings announced that its wholly-owned subsidiary, Singapore Paincare Center @ Novena Pte. Ltd, has leased 775 sq ft unit at #07-33 Mount Elizabeth Novena Specialist Centre for 24 months.
The tenancy agreement was signed with Medbridge Marketing, which is 100%-owned by Singapore Paincare Holdings’ executive chairman, CEO and controlling shareholder, Dr Lee Mun Kam Bernard, making this an interested person transaction (IPT) under the listing rules.
The rental fees will come up to around $547,200, which represents 8.1% of Singapore Paincare Holdings’ latest audited NTA of $6.8 million as at June 30, 2025.
See also: Hiap Hoe expects 'significant' improvement in its FY2025 earnings
The lease will commence on Feb 1.
Singapore Paincare Holdings will release its results on or before Feb 13.
Shares in Singapore Paincare Holdings closed 0.5 cents lower or 4.35% down at 11 cents on Feb 5.
